Medicon A/S initiates a new clinical research unit

In January 2004 Medicon A/S initiates a new activity: Medicon Clinical Pharmacology - a dedicated clinical research unit providing full clinical services for volunteer and patient studies.

The facility is located in Copenhagen 5 min from the Copenhagen University Hospital, Rigshospitalet. The 20 bed unit is equipped with separate screening facilities, video surveillance, telemetry, leisure facilities allowing long term studies, temperature and humidity controlled drug storage and laboratory for handling of samples – thus providing a State of the Art facility both for clients and participants.

Dr. Poul-Martin Haahr will be the new Director of the Clinical Pharmacology unit. He has more than 12 years of experience from the pharma and biotech industry and has for the last year planned and prepared the upstart of this new initiative. The clinical services include all clinical pharmacology studies in healthy volunteers and in patients:

- Single dose ascending tolerance studies - first dose in man

- Multiple dose tolerance studies

- Bioequivalence and bioavailability studies

- Pharmacokinetic and pharmacodynamic studies

- Drug and food interaction studies

Safety comes first: Medicon Clinical Pharmacology comply with the standards of The Association of the British Pharmaceutical Industry for Facilities for Non-Patients Volunteer Studies. In addition to the approval by the regulatory authorities and Ethics Committees, all studies are reviewed by the Internal Safety Board of pharmacology and toxicology experts and physicians.

By this new activity Medicon offers complete drug development solutions to international and local clients from phase I to phase IV. Medicon planning and trial solutions combined with the well developed infrastructure offer clients the optimum basis for any type of clinical study as documented in many studies.

Medicon A/S is a member of Medicon Valley Academy.

More information at www.medicon.dk